157 related articles for article (PubMed ID: 33175262)
1. A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After Surgery.
Fiore M; Brunelli C; Miceli R; Manara M; Lenna S; Rampello NN; Callegaro D; Colombo C; Radaelli S; Pasquali S; Caraceni AT; Gronchi A
Ann Surg Oncol; 2021 Jul; 28(7):3904-3916. PubMed ID: 33175262
[TBL] [Abstract][Full Text] [Related]
2. Long-term quality of life after resection of retroperitoneal soft tissue sarcoma.
Willis F; Buck L; Musa J; Hinz U; Mechtersheimer G; Seidensaal K; Fröhling S; Büchler MW; Schneider M
Eur J Surg Oncol; 2023 Nov; 49(11):106977. PubMed ID: 37481390
[TBL] [Abstract][Full Text] [Related]
3. Long-term morbidity after multivisceral resection for retroperitoneal sarcoma.
Callegaro D; Miceli R; Brunelli C; Colombo C; Sanfilippo R; Radaelli S; Casali PG; Caraceni A; Gronchi A; Fiore M
Br J Surg; 2015 Aug; 102(9):1079-87. PubMed ID: 26041724
[TBL] [Abstract][Full Text] [Related]
4. Retrospective quality of life study in patients with retroperitoneal sarcoma in an Asian population.
Lim HJ; Ong CJ; Skanthakumar T; Mak LYH; Wasudevan SD; Tan JW; Chia CS; Tan GHC; Teo MCC
Health Qual Life Outcomes; 2020 Aug; 18(1):270. PubMed ID: 32762683
[TBL] [Abstract][Full Text] [Related]
5. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.
Judge SJ; Lata-Arias K; Yanagisawa M; Darrow MA; Monjazeb AM; Kirane AR; Bold RJ; Canter RJ; Canter DJ
J Surg Oncol; 2019 Sep; 120(4):753-760. PubMed ID: 31355444
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
7. Surgical morbidity in retroperitoneal sarcoma resection.
MacNeill AJ; Fiore M
J Surg Oncol; 2018 Jan; 117(1):56-61. PubMed ID: 29314041
[TBL] [Abstract][Full Text] [Related]
8. Does Aggressive Surgery Mean Worse Quality of Life and Functional Capacity in Retroperitoneal Sarcoma Patients?-A Retrospective Study of 161 Patients from China.
Zhuang A; Fang Y; Ma L; Yang H; Lu W; Zhou Y; Zhang Y; Tong H
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291911
[TBL] [Abstract][Full Text] [Related]
9. Post-operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS).
Hull MA; Niemierko A; Haynes AB; Jacobson A; Chen YL; DeLaney TF; Mullen JT
J Surg Oncol; 2015 Jul; 112(1):98-102. PubMed ID: 26179132
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.
MacNeill AJ; Gronchi A; Miceli R; Bonvalot S; Swallow CJ; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Barretta F; Raut CP; Strauss DC
Ann Surg; 2018 May; 267(5):959-964. PubMed ID: 28394870
[TBL] [Abstract][Full Text] [Related]
12. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Raman S; Ding K; Chow E; Meyer RM; van der Linden YM; Roos D; Hartsell WF; Hoskin P; Wu JSY; Nabid A; Haas R; Wiggenraad R; Babington S; Demas WF; Wilson CF; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2018 Apr; 27(4):1089-1098. PubMed ID: 29188483
[TBL] [Abstract][Full Text] [Related]
13. Effect of nephrectomy for retroperitoneal sarcoma on post-operative renal function.
Kim DB; Gray R; Li Z; Wasif N; Bagaria SP
J Surg Oncol; 2018 Mar; 117(3):425-429. PubMed ID: 29044533
[TBL] [Abstract][Full Text] [Related]
14. Malnutrition and Perioperative Nutritional Support in Retroperitoneal Sarcoma Patients: Results from a Prospective Study.
Previtali P; Fiore M; Colombo J; Arendar I; Fumagalli L; Pizzocri M; Colombo C; Rampello NN; Mariani L; Gronchi A; Codazzi D
Ann Surg Oncol; 2020 Jun; 27(6):2025-2032. PubMed ID: 31848820
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.
Raimondi A; Di Maio M; Morano F; Corallo S; Lonardi S; Antoniotti C; Rimassa L; Sartore-Bianchi A; Tampellini M; Ritorto G; Murialdo R; Clavarezza M; Zaniboni A; Adamo V; Tomasello G; Petrelli F; Antonuzzo L; Giordano M; Cinieri S; Longarini R; Bergamo F; Niger M; Antista M; Peverelli G; de Braud F; Di Bartolomeo M; Pietrantonio F
Eur J Cancer; 2020 Aug; 135():230-239. PubMed ID: 32623288
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma.
Cho CW; Lee KW; Park H; Kim HJ; Park JB; Choi YL; Yu JI; Lee SJ; Choi DI; Kim SJ
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e465-e471. PubMed ID: 29044883
[TBL] [Abstract][Full Text] [Related]
17. Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life.
Schmidt AH; Høyer M; Jensen BFS; Agerbaek M
Acta Oncol; 2018 Aug; 57(8):1084-1093. PubMed ID: 29537330
[TBL] [Abstract][Full Text] [Related]
18. Transferability of Health-Related Quality of Life Data of Large Observational Studies to Clinical Practice: Comparing Retroperitoneal Sarcoma Patients from the PROSa Study to a TARPS-WG Cohort.
Jakob J; Hentschel L; Richter S; Kreisel I; Hohenberger P; Kasper B; Andreou D; Pink D; Schmitt J; Schuler MK; Eichler M
Oncol Res Treat; 2022; 45(11):660-669. PubMed ID: 35700716
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Quality of Life of Retroperitoneal Sarcoma Patients Treated with Pre-Operative Radiotherapy and Surgery.
Wong P; Kassam Z; Springer AN; Gladdy R; Chung P; Ringash J; Catton C
Cureus; 2017 Oct; 9(10):e1764. PubMed ID: 29234568
[TBL] [Abstract][Full Text] [Related]
20. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
